
High‐intensity interval training slows down tumor progression in mice bearing Lewis lung carcinoma
Author(s) -
Alves Christiano R. R.,
Neves Willian,
Tobias Gabriel C.,
Almeida Ney R.,
Barreto Raphael F.,
Melo Camila M.,
Carneiro Camila de G.,
Garcez Alexandre T.,
Faria Daniele de P.,
Chammas Roger,
Brum Patricia C.
Publication year - 2018
Publication title -
jcsm rapid communications
Language(s) - English
Resource type - Journals
ISSN - 2617-1619
DOI - 10.1002/j.2617-1619.2018.tb00008.x
Subject(s) - high intensity interval training , lewis lung carcinoma , medicine , interval training , angiogenesis , contractility , lung cancer , tumor progression , oncology , cancer , metastasis
Background We aimed to determine whether a short‐term high‐intensity interval training (HIIT) protocol could counteract tumor progression in an experimental model of lung cancer. Methods Mice were injected subcutaneously with Lewis Lung Carcinoma (LLC) cells and then randomly assigned into two groups: sedentary mice (LLC group) or mice submitted to HIIT (LLC + HIIT group). Results LLC + HIIT group had lower tumor mass than LLC group (‐52% after 18 days), with no differences in glycolytic activity as measured by PET/CT imaging. HIIT increased Cd274 (PD‐L1) mRNA expression by ~6 folds and Vegfa mRNA expression by 2.5 folds, suggesting that HIIT stimulates local inflammation and angiogenesis in LLC tumors. Additionally, HIIT improved running capacity, skeletal muscle contractility and survival rate in LLC tumor‐bearing mice. Conclusions These novel findings demonstrate that a short‐term HIIT protocol slows down tumor progression, ultimately increasing survival in LLC tumor‐bearing mice. Thus, this study provides novel pre‐clinical evidence that exercise training may be a beneficial co‐therapy for lung cancer.